Mery Les, Bray Freddie
Cancer Surveillance Section, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.
Ecancermedicalscience. 2020 Jan 16;14:ed95. doi: 10.3332/ecancer.2020.ed95. eCollection 2020.
Timely and accurate data on health enable policymakers to make informed decisions that can reduce the burden and suffering from disease. Yet many LMICs are not able to adequately collect the health indicators necessary to track progress in the Sustainable Development Goals (SDG) at present, and a major investment in primary data collection is needed. We argue that cancer surveillance, with an established history of international standards and best practices, represents a feasible entry point in the development of surveillance programmes for NCDs. The International Agency for Research on Cancer (IARC) has served to support population-based cancer registries (PBCR) since its inception over 50 years ago. Based on this longstanding experience and collaboration with PBCR worldwide, IARC and other key partners implemented the Global Initiative for Cancer Registry Development (GICR, http://gicr.iarc.fr/) as a new way to deliver capacity-building in cancer surveillance. We describe some of the critical aspects of the GICR and the prospects of a step-change in the quality and use of cancer data over the next years. Ultimately, the decision on how to proceed resides with countries. The cancer and NCD burden will not be tackled without committed and sustainable action by governments.
及时且准确的健康数据能使政策制定者做出明智决策,从而减轻疾病负担与痛苦。然而,目前许多低收入和中等收入国家无法充分收集追踪可持续发展目标(SDG)进展所需的健康指标,因此需要对原始数据收集进行重大投资。我们认为,癌症监测有着国际标准和最佳实践的既定历史,是发展非传染性疾病监测项目的一个可行切入点。国际癌症研究机构(IARC)自50多年前成立以来一直致力于支持基于人群的癌症登记处(PBCR)。基于这一长期经验以及与全球PBCR的合作,IARC和其他关键伙伴实施了全球癌症登记发展倡议(GICR,http://gicr.iarc.fr/),作为在癌症监测方面提供能力建设的一种新方式。我们阐述了GICR的一些关键方面以及未来几年癌症数据质量和使用实现重大转变的前景。最终,如何推进的决定权在各国手中。没有各国政府坚定且可持续的行动,癌症和非传染性疾病负担将无法得到解决。